Loading…
YDES
YD Bio Ltd
NASDAQ· Healthcare· Biotechnology· CUSIP G98301107
$4.80+24.03%Price as of Aug 29, 18:47 UTC · updated once a day, after the close
Key metrics
- Market cap
- $339.99M
- P/E
- —
- Forward P/E
- —
- P/B
- 1.1x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.13
- ROE
- -42.69%
- Profit margin
- -276.58%
- Revenue growth
- +95.60%
- Beta
- -0.13
- 52-week high
- $25.00
- 52-week low
- $1.70
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -54.2% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| VMDViemed Healthcare Inc | $8.96 | 24.9x | 2.4x | — | 10.45% | $341.27M |
| EBSEmergent BioSolutions Inc. | $6.67 | — | 1.0x | — | -40.29% | $341.99M |
| CATXPerspective Therapeutics, Inc. | $2.96 | — | 1.0x | — | -39.57% | $337.89M |
| IPSCCentury Therapeutics, Inc. | $1.89 |
About the company
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
- Taipei, Taiwan
Company description provided by Yahoo Finance.